IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $607,000 | +7.2% | 29,900 | -30.0% | 0.02% | +15.0% |
| Q4 2016 | $566,000 | -54.6% | 42,700 | -1.4% | 0.02% | -52.4% |
| Q2 2016 | $1,248,000 | +78.0% | 43,300 | +97.7% | 0.04% | +100.0% |
| Q1 2016 | $701,000 | +38.3% | 21,900 | +36.9% | 0.02% | +16.7% |
| Q4 2014 | $507,000 | -15.8% | 16,000 | -45.6% | 0.02% | -67.3% |
| Q3 2013 | $602,000 | -19.9% | 29,400 | -22.0% | 0.06% | -28.6% |
| Q2 2013 | $752,000 | – | 37,700 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |